St. Louis, MO

Founded in 1975, Lee Biosolutions, Inc., has nearly 40 years' experience providing finished proteins and enzymes to researchers and manufacturers around the world. Producing and supplying antigens and high purity finished proteins, the healthcare biotechnology firm, located in St. Louis, Missouri, and led by President Burton Lee, has grown into a preferred source of lymphoma and myeloma tumor markers. One such product is called Beta 2 Microglobulin (B2M); this plasma protein helps in the diagnos...

Founded in 1975, Lee Biosolutions, Inc., has nearly 40 years' experience providing finished proteins and enzymes to researchers and manufacturers around the world. Producing and supplying antigens and high purity finished proteins, the healthcare biotechnology firm, located in St. Louis, Missouri, and led by President Burton Lee, has grown into a preferred source of lymphoma and myeloma tumor markers. One such product is called Beta 2 Microglobulin (B2M); this plasma protein helps in the diagnosis and prognosis of blood cell cancers. As a leader in blood cell cancer research, Lee Biosolutions, Inc., appreciates its dynamic role in the detection and treatment of kidney damage and blood cancers.